These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 4199716)

  • 21. Heterologous Boost Following
    Wu Y; Cai M; Ma J; Teng X; Tian M; Bassuoney EBMB; Fan X
    Front Immunol; 2018; 9():2439. PubMed ID: 30425711
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The efficacy of live tuberculosis vaccines after presensitization with Mycobacterium avium.
    de Lisle GW; Wards BJ; Buddle BM; Collins DM
    Tuberculosis (Edinb); 2005; 85(1-2):73-9. PubMed ID: 15687030
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of immune responses of mice immunized with five different Mycobacterium bovis BCG vaccine strains.
    Lagranderie MR; Balazuc AM; Deriaud E; Leclerc CD; Gheorghiu M
    Infect Immun; 1996 Jan; 64(1):1-9. PubMed ID: 8557324
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tuberculin shock in red mice and CF1 mice immunized with strains of BCG or Mycobacterium tuberculosis.
    Jespersen A
    Acta Pathol Microbiol Scand B; 1976 Oct; 84B(5):273-79. PubMed ID: 823795
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Heat-Shock Protein gp96 Enhances T Cell Responses and Protective Potential to Bacillus Calmette-Guérin Vaccine.
    Ding Y; Zheng H; Feng C; Wang B; Liu C; Mi K; Cao H; Meng S
    Scand J Immunol; 2016 Oct; 84(4):222-8. PubMed ID: 27417661
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lactoferrin augments BCG vaccine efficacy to generate T helper response and subsequent protection against challenge with virulent Mycobacterium tuberculosis.
    Hwang SA; Kruzel ML; Actor JK
    Int Immunopharmacol; 2005 Mar; 5(3):591-9. PubMed ID: 15683854
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mycobacterial sensitivity elicited with a PPD devoided of the majority of the antigens common with BCG. Results on healthy-BCG vaccinated and tuberculous children.
    Stavri D; Claiciu I; Bărbulescu R; Stavri H; Niculescu D; Calciu B; Calciu M
    Arch Roum Pathol Exp Microbiol; 1983; 42(2-3):221-6. PubMed ID: 6424630
    [No Abstract]   [Full Text] [Related]  

  • 28. Enhancement of antimycobacterial Th1-cell responses by a Mycobacterium bovis BCG prime-protein boost vaccination strategy.
    Lu M; Xia ZY; Bao L
    Cell Immunol; 2013; 285(1-2):111-7. PubMed ID: 24177251
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunogenicity and protective efficacy of recombinant Bacille Calmette-Guerin strains expressing mycobacterium antigens Ag85A, CFP10, ESAT-6, GM-CSF and IL-12p70.
    Dai FY; Wang JF; Gong XL; Bao L
    Hum Vaccin Immunother; 2017 Jun; 13(6):1-8. PubMed ID: 28301284
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunogenicity of living and heat-killed Salmonella pullorum vaccines.
    Collins FM
    Infect Immun; 1973 May; 7(5):735-42. PubMed ID: 4587521
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A new tool for tuberculosis vaccine screening: Ex vivo Mycobacterial Growth Inhibition Assay indicates BCG-mediated protection in a murine model of tuberculosis.
    Zelmer A; Tanner R; Stylianou E; Damelang T; Morris S; Izzo A; Williams A; Sharpe S; Pepponi I; Walker B; Hokey DA; McShane H; Brennan M; Fletcher H
    BMC Infect Dis; 2016 Aug; 16():412. PubMed ID: 27519524
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mycobacterium bovis BCG vaccination modulates TNF-alpha production after pulmonary challenge with virulent Mycobacterium tuberculosis in guinea pigs.
    Yamamoto T; Lasco TM; Uchida K; Goto Y; Jeevan A; McFarland C; Ly L; Yamamoto S; McMurray DN
    Tuberculosis (Edinb); 2007 Mar; 87(2):155-65. PubMed ID: 17289434
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunization of mice with the antigen A60 of Mycobacterium bovis BCG.
    Hubbard RD; Flory CM; Collins FM; Cocito C
    Clin Exp Immunol; 1992 Apr; 88(1):129-31. PubMed ID: 1563099
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Virulence, immunogenicity, and protective efficacy of two recombinant Mycobacterium bovis bacillus Calmette-Guérin strains expressing the antigen ESAT-6 from Mycobacterium tuberculosis.
    Bao L; Chen W; Zhang H; Wang X
    Infect Immun; 2003 Apr; 71(4):1656-61. PubMed ID: 12654778
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A live attenuated BCG vaccine overexpressing multistage antigens Ag85B and HspX provides superior protection against Mycobacterium tuberculosis infection.
    Yuan X; Teng X; Jing Y; Ma J; Tian M; Yu Q; Zhou L; Wang R; Wang W; Li L; Fan X
    Appl Microbiol Biotechnol; 2015 Dec; 99(24):10587-95. PubMed ID: 26363555
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anti-tuberculosis drug susceptibility testing of Mycobacterium bovis BCG Tokyo strain.
    Shishido Y; Mitarai S; Otomo K; Seki M; Sato A; Yano I; Koyama A; Hattori T
    Int J Tuberc Lung Dis; 2007 Dec; 11(12):1334-8. PubMed ID: 18034955
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evidence inconsistent with a role for the Bcg gene (Nramp1) in resistance of mice to infection with virulent Mycobacterium tuberculosis.
    Medina E; North RJ
    J Exp Med; 1996 Mar; 183(3):1045-51. PubMed ID: 8642246
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recombinant BCG Tokyo (Ag85A) protects cynomolgus monkeys (Macaca fascicularis) infected with H37Rv Mycobacterium tuberculosis.
    Sugawara I; Li Z; Sun L; Udagawa T; Taniyama T
    Tuberculosis (Edinb); 2007 Nov; 87(6):518-25. PubMed ID: 17720625
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vaccination of guinea pigs with BCGΔBCG1419c transiently reduces hematogenous spread of M. tuberculosis to the spleen.
    Aceves-Sánchez MJ; Flores-Valdez MA; Shanley C; Orme I; Bielefeldt-Ohmann H
    Pathog Dis; 2018 Dec; 76(9):. PubMed ID: 30500936
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vaccination of neonatal calves with Mycobacterium bovis BCG induces protection against intranasal challenge with virulent M. bovis.
    Hope JC; Thom ML; Villarreal-Ramos B; Vordermeier HM; Hewinson RG; Howard CJ
    Clin Exp Immunol; 2005 Jan; 139(1):48-56. PubMed ID: 15606613
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.